The purpose of this study is to collect information about people with fibrolamellar cancer (FLC). This study is a registry of people with FLC around the world. This study will involve collecting information about participants, their medical history and the regular medical care they receive for FLC. The study will not provide treatment for your cancer.
Study Type
OBSERVATIONAL
Enrollment
12
The questionnaire will be completed at the time of enrollment, every month, and at the end of study. Regardless of current interventions or lack of, assessments will be completed at enrollment and then monthly for a total of 18 months. In order to provide reasonable flexibility to participants, physicians, and study teams, the assessments can be completed within 30 days of the last assessment. The next month will be recalculated based on last reporting date.
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States
Build a Fibrolamellar Cancer/FLC registry
To build a registry of Fibrolamellar Cancer/FLC through patient reported information, that could be studied further in future studies.
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.